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Throughout the last 15 years, the Hippo pathway has been
shown to be one of the most intriguing signaling pathway
found to fulfil a crucial role in regulating multiple cellular
functions, such as proliferation, apoptosis, regeneration
and organ size control. This pathway was first identified in
Drosophila melanogaster, but it was primarily investigated in
tumorigenesis, given its relevance also for human cancer.1
Hippo has been conserved during evolution, and accumulat-
ing studies supported its tumorigenic involvement during
mammal development.2,3 Central modulators of Hippo path-
way are the transcriptional coactivators YAP and TAZ, which
shuttle between the cytoplasm and the nucleus. Noteworthy,
when Hippo is activated, YAP and TAZ are phosphorylated
and retained in the cytoplasm, so that their downstream genes
are inactivated. Conversely, when Hippo is inactive, YAP and
TAZ translocate into the nucleus, enabling the transcription of
target genes involved in cell proliferation, survival and
tumorigenesis.3
Merlin is a cytoskeleton-associated protein belonging
to the ERM (ezrin-radixin-moesin) family, which serves as
tumor-suppressor protein in different cells. Mutations in the
neurofibromin gene (Nf2), encoding merlin, are associated
with the autosomal dominant multiple syndrome called
neurofibromatosis type 2.4 Merlin is an upstream activator of
Hippo,5 and currently, Nf2 is considered the only gene of the
Hippo pathway that is found to be inactivated via a mutation in
cancer, as for example, in vestibular schwannoma.
Recently, a manuscript by K-L Guan et al.6 reviewed the
emerging functions of Hippo, focusing on a new role of YAP and
TAZ in cancer progression. They pointed to extracellular
factors, mechanotransduction and cell-to-cell adhesion
mechanisms as YAP and TAZ regulators. Furthermore, the
capability of Hippo/YAP in controlling stem cell renewal and
expansion was also demonstrated in mammals and humans.5,7
The complexity of Hippo/YAP pathway increased consider-
ably in the recent years, and other tissues and cells, for
instance those forming the nervous system, were proved to be
an interesting target of investigation. In vertebrates, YAP may
regulate neural progenitor cell number during the central
nervous system development.8 Therefore, YAP has been
appointed as one of the master regulator of neural, as well as
glial, progenitor cells in the central nervous system. Hitherto,
very few studies tried to elucidate the Hippo/YAP involvement
in controlling the biological processes in neural and glial cells
of the peripheral nervous system.
Now, we published in Cell Death and Discovery that the
Hippo/YAP intracellular signaling pathway has an important
role in regulating some biological processes in the main glial
cells of the peripheral nervous system, the Schwann cells
(SC), see Figure 1.9 Our findings also corroborated the
hypothesis that merlin is involved in modulating the Hippo
pathway.5 In the manuscript, Colciago et al. showed that some
genes, known to be upstream or downstream mediators of
Hippo (for instance, Amotl2, Dchs, Fat or Wnt1) were changed
in SC exposed to an environmental challenge, such as a 50-
Hz electromagnetic field.9 It is generally known that YAP is
also implicated in the Crb/Amotl tight junction signaling
serving as tumor suppressor to limit the adhesion-related cell
growth.10 We found that, in SC, the dysregulation of the Hippo/
YAP pathway, produced YAP downregulation, increased cell
proliferation and decreased differentiation. In summary, we
showed that a cascade of coordinated mechanisms,
involving tight junction alterations, decrease in merlin levels,
SC migration, increase of the chemo-responsivity, YAP
downregulation and redistribution, altogether reduce Hippo
pathway activation in SC. This, in turn, may participate in
controlling the fate of SC following an environmental
challenge.9 Indeed, some recent data suggested that YAP,
besides its oncogenic potential in several cancers, might also
display tumor-suppressor functions in different cellular con-
text. Therefore, the observed changes in cellular distribution
and the augmented availability of YAP in the SC cytoplasm, as
we proposed,9 might account for its capability to induce cell
oncogenic transformation.
The interest of researchers in Hippo/YAP proteins in SC
development and myelination is recently raising, as witnessed
by the data from Parkinson and co-workers.11 They showed
that this pathway is likely activated following the loss of merlin
in SC, causing a large increase in SC proliferation and defects
in axonal regeneration.11
Moreover, novel insights on the importance of Hippo/YAP
signaling in the peripheral nervous system have been
provided by Serinagaoglu et al.12 These authors described
how YAP and TAZ are expressed in migratory neural crest
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cells, in dorsal root ganglion (DRG) progenitors and peripheral
glial cells (mostly satellite glial cells), but not in neuronal
lineage. YAP was inhibited by merlin during normal DRG
development, while the loss of Nf2 led to YAP hyperactivation,
overexpansion of DRG progenitors and glial cells, concomi-
tantly to a reduction of neuron development.12 These findings
supported a YAP-mediated signaling during neural crest
development. Unraveling these mechanisms may have
important future clinical implications.
The environmental control of Hippo/YAP might have a
relevant socioeconomic impact. The low-frequency (20 Hz)
electromagnetic fields have long been proposed as therapy to
promote peripheral nerve regeneration,13 whereas the 50-Hz
electromagnetic fields are largely used in several medical
tools and in common electric devices, for instance, the mobile
phones. However, the risk to develop vestibular schwanno-
mas, coming from the long-term use of wireless phones, is still
unclear and debated, although clinical outcomes seem to
corroborate this pathogenic correlation.14 Further studies are
needed to support this hypothesis, but people should be
aware that these scientific issues are open and very actual,
and should be carefully considered for human health.
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Figure 1 Model of Hippo/YAP involvement in Schwann cells of the peripheral nervous system. Hippo/YAP participate in forming tight junction and cell-to-cell adhesion in
Schwann cells. A potential injury or an environmental challenge, as the exposure to a 50-Hz electromagnetic field, may induce a merlin-dependent Hippo/YAP activation, in turn
affecting cell proliferation, migration, chemotactic responsivity and differentiation. In principle, these mechanisms are supposed to be involved in nerve tumorigenesis and
schwannoma development9
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